von Moltke Lisa

von Moltke Lisa is listed in filings as See Remarks at Zenas BioPharma, Inc.. This profile follows SEC Form 4 activity through Apr 17, 2025, including sale activity. Recent filings connect the profile to Zenas BioPharma, Inc. (ZBIO) and Seres Therapeutics, Inc. (MCRB). The current snapshot covers public activity from Aug 19, 2024 to Apr 17, 2025. Reported amounts are shown as $3.5M to $3.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.